A novel series of N-methylpicolinamide-4-thiol derivatives were synthesized and evaluated on human cancer cell lines. Among them, compound 6p displayed potent and broad-spectrum anti-proliferative activities in vitro on some human cancer cell lines, even better than sorafenib. The advanced kinase inhibitory assays showed that compound 6p could selectively inhibit Aurora-B kinase. The biological results were rationalized by the molecular docking study, which indicated the stable interactions of 6p with the Aurora-B kinase. © 2012 by the authors.
CITATION STYLE
Huang, T. T., Huang, Y. C., Qing, X. Y., Xia, Y., Luo, X., Ye, T. H., & Yu, L. T. (2012). Synthesis and biological evaluation of novel N-methyl-picolinamide-4-thiol derivatives as potential antitumor agents. Molecules, 17(6), 6317–6330. https://doi.org/10.3390/molecules17066331
Mendeley helps you to discover research relevant for your work.